EcoDrugPlus

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSATEG00000001570
Gene Symbol: IMPDH1
3 Cross references
259 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSATEG00000011360
Gene Symbol: INPP5D
2 Cross references
216 Possible Orthologues:

Insulin Receptor A

Ensembl ID : ENSATEG00000021893
Gene Symbol: INSRA
3 Cross references
230 Possible Orthologues:

Insulin Receptor B

Ensembl ID : ENSATEG00000008275
Gene Symbol: INSRB
3 Cross references
201 Possible Orthologues:

Insulin-Like Growth Factor 1a Receptor

Ensembl ID : ENSATEG00000004963
Gene Symbol: IGF1RA
1 Cross references
206 Possible Orthologues:

Insulin-Like Growth Factor 1b Receptor

Ensembl ID : ENSATEG00000004408
Gene Symbol: IGF1RB
2 Cross references
204 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSATEG00000006925
Gene Symbol: LOC113154463
2 Cross references
196 Possible Orthologues:

Integrin Beta-3

Ensembl ID : ENSATEG00000021883
Gene Symbol: LOC113156567
2 Cross references
195 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSATEG00000000914
Gene Symbol: LOC113157876
3 Cross references
204 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSATEG00000005299
Gene Symbol: ITGA4
3 Cross references
226 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSATEG00000010857
Gene Symbol: ITGB1
3 Cross references
230 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSATEG00000015429
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).